Diabetic Nephropathy Type 2: Clinical Trials

32 trials for Diabetic Nephropathy Type 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 9 unknown, 6 not yet recruiting, 4 recruiting. 8 Phase 2, 6 Not applicable, 4 Phase 1, 4 Phase 3, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 28Not yet recruiting 3, Unknown 3, Active not recruiting 1, Recruiting 1
Not applicable6Completed 2, Unknown 2, Not yet recruiting 1, Recruiting 1
Phase 14Completed 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 34Not yet recruiting 2, Completed 1, Unknown 1
Phase 43Completed 1, Unknown 1, Withdrawn 1
Early Phase 11Completed 1

Follow Diabetic Nephropathy Type 2: new trials by email Literature Review of Diabetic Nephropathy Type 2 trials Research Report on Diabetic Nephropathy Type 2

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Beta-2-Trace Protein in Diabetic Nephropathy
Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus
Not yet recruitingAssiut University802026-11-102026-11-05
Vitamin D in Diabetic Neuropathy
Vitamin D - Diabetic Nephropathy Type 2
Phase 2 / Phase 3Not yet recruitingTanta University1502026-10-012026-09-08
Human Umbilical Cord Mesenchymal Stem Cell Infusion for Type 2 Diabetic Nephropathy
Human umbilical cord mesenchymal stem cell injection - Diabetic Nephropathy Type 2
Phase 1 / Phase 2Not yet recruitingThe First People's Hospital of Changzhou492026-09-012026-08-18
Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial
Umbilical Cord Mesenchymal Stem Cells - Diabetic Nephropathy Type 2
Phase 1 / Phase 2RecruitingPT. Prodia Stem Cell Indonesia102026-07-012026-02-09
Research on Innovative Traditional Chinese Medicine Diagnosis and Treatment Technologies for Diabetic Nephropathy Driven by Multi-Omics and Artificial Intelligence
Jiajian Yishen Xiaozheng Qufeng Granules - Diabetic Nephropathy Type 2, Chronic Renal Failure/ Kidney Disease
Not applicableNot yet recruitingJiazhen Yin1982026-03-122026-03-10
Relationship of Serum Zinc Level With Severity of Diabetic Nephropathy
Diabetic Nephropathy Type 2
Not yet recruitingAssiut University922025-12-012024-11-15
Clinical Utility of a Genomic Predictor Test on the Management of Cardiorenal Complications of Type 2 Diabetes
Polygenic Risk Score - Diabetes Mellitus, Type 2, Cardiovascular Diseases
Not applicableRecruitingOptithera27142024-08-232024-09-19
Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status
clinical periodontal measurements, serum samples, saliva samples - Diabetic Nephropathy Type 2, Type 2 Diabetes
CompletedPamukkale University1262024-06-102026-03-27
Effect of Exercise Therapy on Type II Diabetic Neuropathic Patients
Experimental group 1 :Ball training, Experimental group 2 :Frenkel Exercises, Control Group - Diabetic Nephropathy Type 2
Not applicableCompletedDr. Sobia Hasan902024-05-052024-12-31
Effect of Dorzagliatin on Renal Function Outcomes in People With Type 2 Diabetes: a Multicentric, Prospective, Randomized Study.
Dorzagliatin, Gliclazide - Diabetic Nephropathy Type 2
Not applicableUnknownYan Bi1062024-02-202024-01-24
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Acetylsalicylic Acid, Placebo - Diabetic Nephropathy Type 2
Phase 2 / Phase 3Not yet recruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine3552024-01-012023-10-05
Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease
Empagliflozin 25 MG, Enalapril Maleate 20 mg - Diabetic Nephropathy Type 2
Phase 2 / Phase 3UnknownOmar Tarek Elfarargi2122023-03-012022-05-13
Multidimensional Accurate Diagnosis and Treatment Technology and Clinical Transformation of Type 2 Diabetes Nephropathy
Diabetic Nephropathy Type 2, Diabetic Kidney Disease
RecruitingChinese PLA General Hospital20002022-08-012023-06-05
Impact of Dapagliflozin as Add-on Therapy on Glycemic Status and Quality of Life in Type 2 Diabetic Patients
Dapagliflozin - Diabetic Nephropathy Type 2
Phase 4CompletedMohammed Mahmood Mohammed402022-05-012024-03-22
Research on Gut Microbiota and Metabolomics in Diabetic Kidney Disease
Diabetic Nephropathy Type 2, Type 2 Diabetes Mellitus (T2DM)
CompletedThe First Affiliated Hospital of Hunan University of Traditional Chinese Medicine5562022-04-182026-08-12
Investigational and Comparative Study in the Management of Diabetic Nephropathy
Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet - Diabetic Nephropathy Type 2
Phase 3CompletedTanta University902022-02-012024-05-14
Relationship Between Serum N/OFQ and Type 2 Diabetic Nephropathy
Enzyme linked immunosorbent assay - Diabetic Nephropathy Type 2
UnknownZheng Guo1802021-08-012021-07-15
Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.
Diabetic Nephropathy Type 2, Biomarker
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine10002021-05-012021-07-20
Atrasentan in Patients With Proteinuric Glomerular Diseases
Atrasentan - IgA Nephropathy, Focal Segmental Glomerulosclerosis
Phase 2Active not recruitingNovartis Pharmaceuticals1032021-03-152026-06-01
Sleep Apnea, Coronary Atherosclerosis and Heart Failure in Diabetes Patients With Nephropathy
Sleep Apnea, Diabetic Nephropathy Type 2
CompletedUniversity of Aarhus742020-10-012022-02-07

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Diabetic Nephropathies (10)  ·  Diabetes Mellitus, Type 2 (8)  ·  Kidney Diseases (3)  ·  Renal Insufficiency, Chronic (3)  ·  Albuminuria (1)  ·  Cardiovascular Diseases (1)  ·  Coronary Artery Disease (1)  ·  Diabetes Mellitus (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Diabetic Neuropathies (1)  ·  Disease (1)  ·  Genetic Risk Score (1)  ·  Gingivitis (1)  ·  Glomerulonephritis, IGA (1)  ·  Glomerulosclerosis, Focal Segmental (1)

Broader conditions

Endocrine System Diseases (14)  ·  Diabetes Mellitus (13)  ·  Female Urogenital Diseases (13)  ·  Female Urogenital Diseases and Pregnancy Complications (13)  ·  Male Urogenital Diseases (13)  ·  Urogenital Diseases (13)  ·  Urologic Diseases (13)  ·  Diabetes Complications (11)  ·  Kidney Diseases (10)  ·  Metabolic Diseases (9)  ·  Nutritional and Metabolic Diseases (9)  ·  Glucose Metabolism Disorders (8)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Pathologic Processes (5)  ·  Disease Attributes (4)

Interventions

Enalapril (2)  ·  empagliflozin (2)  ·  Asian ginseng (1)  ·  Aspirin (1)  ·  Atrasentan (1)  ·  Clinical Laboratory Techniques (1)  ·  Continuous Glucose Monitoring (1)  ·  Control Groups (1)  ·  Dorzagliatin (1)  ·  Eplerenone (1)  ·  Gestyl (1)  ·  Gliclazide (1)  ·  Linagliptin (1)  ·  Lisinopril (1)  ·  Losartan (1)

Sponsors

Assiut University (3)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Shanghai University of Traditional Chinese Medicine (2)  ·  Tanta University (2)  ·  Beni-Suef University (1)  ·  Centro Universitario de Ciencias de la Salud, Mexico (1)  ·  Chang Gung Memorial Hospital (1)  ·  Chinese PLA General Hospital (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Dr. Sobia Hasan (1)  ·  James A. Tumlin, MD (1)  ·  Jiazhen Yin (1)  ·  Leiden University Medical Center (1)  ·  Mayo Clinic (1)  ·  Mohammed Mahmood Mohammed (1)

Countries

China (7)  ·  Denmark (3)  ·  United States (3)  ·  Egypt (2)  ·  Italy (2)  ·  Australia (1)  ·  Canada (1)  ·  Indonesia (1)  ·  Iraq (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Pakistan (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Yueyi Deng, PhD (2)  ·  Aftab Ahmed Mirza Baig, PhD (1)  ·  Chao Zheng, MD,PhD (1)  ·  Dina A Mohammed, prof (1)  ·  Jakob T. Nyvad, MD (1)  ·  Juan Huang, Doctor (1)  ·  LaTonya J Hickson, MD (1)  ·  Mostafa O El Mokadem, M.D. (1)  ·  Niels H. Buus, MD PhD DMSc (1)  ·  Omar T Elfarargi (1)  ·  Pavel Hamet, MD, PhD (1)  ·  Rong Yu, Doctor (1)  ·  Sebastian Nielsen, MD student (1)  ·  Sobia Hasan, PhD* (1)

Results publications

PMID 32848436, PMID 33131308, PMID 34533892, PMID 34788550, PMID 34940288, PMID 37254256, PMID 38600065, PMID 38915115, PMID 39228893, PMID 39899371, PMID 40938675, PMID 41141513, PMID 41442197